MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

09 Aug 2025 Evaluate
The June 2025 quarter revenue stood at Rs. 1960.47 millions, up 19.21% as compared to Rs. 1644.51 millions during the corresponding quarter last year.Modest increase of 11.51% in the Net Profit was reported from. 163.28 millions to Rs. 182.08  millions.The company reported a good operating profit of 394.54 millions compared to 348.33 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1960.47 1644.51 19.21 1960.47 1644.51 19.21 7827.48 7092.63 10.36
Other Income 5.93 13.68 -56.65 5.93 13.68 -56.65 62.24 44.60 39.55
PBIDT 394.54 348.33 13.27 394.54 348.33 13.27 1461.98 1213.04 20.52
Interest 58.40 46.67 25.13 58.40 46.67 25.13 185.41 234.57 -20.96
PBDT 336.14 301.66 11.43 336.14 301.66 11.43 1276.57 978.47 30.47
Depreciation 97.52 83.82 16.34 97.52 83.82 16.34 343.37 315.16 8.95
PBT 238.62 217.84 9.54 238.62 217.84 9.54 933.20 663.31 40.69
TAX 56.54 54.56 3.63 56.54 54.56 3.63 249.39 169.07 47.51
Deferred Tax 6.54 1.56 319.23 6.54 1.56 319.23 52.99 17.79 197.86
PAT 182.08 163.28 11.51 182.08 163.28 11.51 683.81 494.24 38.36
Equity 88.65 84.65 4.73 88.65 84.65 4.73 88.65 84.65 4.73
PBIDTM(%) 20.12 21.18 -4.99 20.12 21.18 -4.99 18.68 17.10 9.21
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..